Frontlight ResearchEarly access
Trial site
UCLA Ronald Reagan Medical Center
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Acute lymphoblastic leukaemia2 trials
- Aortic stenosis1 trial
- Chronic lymphocytic leukaemia1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 13 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Akeso1 trial
- Beat AML, LLC1 trial
- Fate Therapeutics1 trial
- Kardigan, Inc.1 trial
- Kura Oncology, Inc.1 trial
- and 3 more
Running trials
Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Recruiting
Recruiting
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Active, not recruiting
Active, not recruiting
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Aortic stenosis1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026